Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.

Saved in:
Bibliographic Details
Title: Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.
Authors: Varela V; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay., Costa M; Xeptiva Therapeutics, Montevideo 11.300, Uruguay., Maciel C; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay., Barbeito J; Xeptiva Therapeutics, Montevideo 11.300, Uruguay., Barrera EE; Instituto de Histología y Embriología de Mendoza (IHEM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina., Gutierre E; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay., Correa A; Protein Engineering Unit, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay., Elgue M; Xeptiva Therapeutics, Montevideo 11.300, Uruguay., Carrasco S; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay., Larrosa MD; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Unidad de Clínica y Cirugía de Pequeños Animales, Facultad de Veterinaria, UdelaR, Montevideo 13000, Uruguay., Pereira M; Xeptiva Therapeutics, Montevideo 11.300, Uruguay., Correa J; Xeptiva Therapeutics, Montevideo 11.300, Uruguay., Crosignani N; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay., Beckman JS; e-MSion Inc., 2121 NE Jack London Street, Corvallis, OR 97330, United States.; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, 97331, United States., Barbeito L; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay., Trias E; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.
Source: Biotechnology reports (Amsterdam, Netherlands) [Biotechnol Rep (Amst)] 2026 Jan 12; Vol. 49, pp. e00946. Date of Electronic Publication: 2026 Jan 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101637426 Publication Model: eCollection Cited Medium: Print ISSN: 2215-017X (Print) Linking ISSN: 2215017X NLM ISO Abbreviation: Biotechnol Rep (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41608074
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Varela+V%22">Varela V</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.<br /><searchLink fieldCode="AU" term="%22Costa+M%22">Costa M</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.<br /><searchLink fieldCode="AU" term="%22Maciel+C%22">Maciel C</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.<br /><searchLink fieldCode="AU" term="%22Barbeito+J%22">Barbeito J</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.<br /><searchLink fieldCode="AU" term="%22Barrera+EE%22">Barrera EE</searchLink>; Instituto de Histología y Embriología de Mendoza (IHEM), Universidad Nacional de Cuyo, CONICET, Mendoza, Argentina.<br /><searchLink fieldCode="AU" term="%22Gutierre+E%22">Gutierre E</searchLink>; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay.<br /><searchLink fieldCode="AU" term="%22Correa+A%22">Correa A</searchLink>; Protein Engineering Unit, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.<br /><searchLink fieldCode="AU" term="%22Elgue+M%22">Elgue M</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.<br /><searchLink fieldCode="AU" term="%22Carrasco+S%22">Carrasco S</searchLink>; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay.<br /><searchLink fieldCode="AU" term="%22Larrosa+MD%22">Larrosa MD</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Unidad de Clínica y Cirugía de Pequeños Animales, Facultad de Veterinaria, UdelaR, Montevideo 13000, Uruguay.<br /><searchLink fieldCode="AU" term="%22Pereira+M%22">Pereira M</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.<br /><searchLink fieldCode="AU" term="%22Correa+J%22">Correa J</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.<br /><searchLink fieldCode="AU" term="%22Crosignani+N%22">Crosignani N</searchLink>; Unidad de Farmacología, Departamento de Clínicas y Hospital Veterinario, Facultad de Veterinaria, UdelaR, Montevideo 13.000, Uruguay.<br /><searchLink fieldCode="AU" term="%22Beckman+JS%22">Beckman JS</searchLink>; e-MSion Inc., 2121 NE Jack London Street, Corvallis, OR 97330, United States.; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, 97331, United States.<br /><searchLink fieldCode="AU" term="%22Barbeito+L%22">Barbeito L</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.<br /><searchLink fieldCode="AU" term="%22Trias+E%22">Trias E</searchLink>; Xeptiva Therapeutics, Montevideo 11.300, Uruguay.; Neurodegeneration Lab, Institut Pasteur de Montevideo, Montevideo 11.400, Uruguay.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637426%22">Biotechnology reports (Amsterdam, Netherlands)</searchLink> [Biotechnol Rep (Amst)] 2026 Jan 12; Vol. 49, pp. e00946. <i>Date of Electronic Publication: </i>2026 Jan 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2E+V%22">Elsevier B. V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101637426 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2215-017X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222215017X%22">2215017X </searchLink><i>NLM ISO Abbreviation: </i>Biotechnol Rep (Amst) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41608074
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.btre.2026.e00946
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e00946
    Titles:
      – TitleFull: Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Varela V
      – PersonEntity:
          Name:
            NameFull: Costa M
      – PersonEntity:
          Name:
            NameFull: Maciel C
      – PersonEntity:
          Name:
            NameFull: Barbeito J
      – PersonEntity:
          Name:
            NameFull: Barrera EE
      – PersonEntity:
          Name:
            NameFull: Gutierre E
      – PersonEntity:
          Name:
            NameFull: Correa A
      – PersonEntity:
          Name:
            NameFull: Elgue M
      – PersonEntity:
          Name:
            NameFull: Carrasco S
      – PersonEntity:
          Name:
            NameFull: Larrosa MD
      – PersonEntity:
          Name:
            NameFull: Pereira M
      – PersonEntity:
          Name:
            NameFull: Correa J
      – PersonEntity:
          Name:
            NameFull: Crosignani N
      – PersonEntity:
          Name:
            NameFull: Beckman JS
      – PersonEntity:
          Name:
            NameFull: Barbeito L
      – PersonEntity:
          Name:
            NameFull: Trias E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 01
              Text: 2026 Jan 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2215-017X
          Numbering:
            – Type: volume
              Value: 49
          Titles:
            – TitleFull: Biotechnology reports (Amsterdam, Netherlands)
              Type: main
ResultId 1